US v. Teva Pharmaceuticals USA, Inc., et al
| UNITED STATES |
| TEVA PHARMACEUTICALS USA, INC. and TEVA NEUROSCIENCE, INC. |
| 23-1958 |
| November 20, 2023 |
| U.S. Court of Appeals, First Circuit |
| Qui Tam False Claims Act |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 20, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| CIVIL CASE docketed. Notice of appeal (doc. #196) filed by Appellants Teva Neuroscience, Inc. and Teva Pharmaceuticals USA, Inc.. Fee due 12/05/2023 . Appearance form, Docketing Statement and Transcript Report/Order form due 12/05/2023 . [23-1958] (GB) [Entered: 11/21/2023 05:22 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
